UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 197.441
NA - Nord America 10.230
AS - Asia 4.253
SA - Sud America 660
Continente sconosciuto - Info sul continente non disponibili 402
AF - Africa 114
OC - Oceania 11
Totale 213.111
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 195.097
US - Stati Uniti d'America 10.045
SG - Singapore 1.675
CN - Cina 1.443
SE - Svezia 585
UA - Ucraina 552
BR - Brasile 500
VN - Vietnam 376
DE - Germania 266
GB - Regno Unito 243
FI - Finlandia 220
FR - Francia 214
HK - Hong Kong 185
IN - India 106
CA - Canada 103
KR - Corea 81
BD - Bangladesh 68
AR - Argentina 54
NL - Olanda 53
IQ - Iraq 52
PL - Polonia 46
TR - Turchia 40
MX - Messico 37
JP - Giappone 32
AT - Austria 31
ZA - Sudafrica 31
ES - Italia 29
PK - Pakistan 25
UZ - Uzbekistan 24
RU - Federazione Russa 23
CO - Colombia 21
MA - Marocco 21
ID - Indonesia 20
VE - Venezuela 20
EC - Ecuador 18
CL - Cile 16
SA - Arabia Saudita 16
PH - Filippine 15
IL - Israele 14
JM - Giamaica 14
BE - Belgio 13
EG - Egitto 13
IE - Irlanda 12
PY - Paraguay 12
CH - Svizzera 11
CZ - Repubblica Ceca 11
KE - Kenya 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
EU - Europa 9
AZ - Azerbaigian 8
PE - Perù 8
AU - Australia 7
BO - Bolivia 7
JO - Giordania 7
MY - Malesia 7
DO - Repubblica Dominicana 6
IR - Iran 6
LT - Lituania 6
NP - Nepal 6
ET - Etiopia 5
HN - Honduras 5
KZ - Kazakistan 5
OM - Oman 5
PT - Portogallo 5
DZ - Algeria 4
TH - Thailandia 4
AL - Albania 3
CI - Costa d'Avorio 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
MU - Mauritius 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
Totale 212.698
Salva come PNG Salva come JPEG
Città #
Cagliari 190.711
Uta 3.837
Ashburn 921
Fairfield 915
Singapore 827
Woodbridge 641
San Jose 580
Dallas 435
Chandler 426
Houston 425
Boardman 399
Ann Arbor 383
Seattle 346
Wilmington 340
Nyköping 336
Cambridge 301
Jacksonville 272
Beijing 268
Los Angeles 227
Council Bluffs 218
Dearborn 194
Hong Kong 168
Santa Clara 160
New York 157
Helsinki 137
Shanghai 130
Ho Chi Minh City 119
Hefei 115
Lauterbourg 114
Nanjing 107
Boston 104
Seoul 79
Hanoi 72
Buffalo 70
The Dalles 67
Atlanta 58
San Diego 54
Guangzhou 49
London 49
Milan 48
Orem 47
Dong Ket 46
São Paulo 45
Warsaw 42
San Francisco 41
Chicago 40
Rome 40
Frankfurt am Main 39
Munich 39
Nanchang 39
Denver 35
Columbus 33
Hebei 32
Shenyang 32
Redwood City 29
Montreal 28
Redondo Beach 27
Tianjin 27
Tokyo 27
Brooklyn 26
Toronto 26
Washington 26
Baghdad 25
Mountain View 24
Jiaxing 22
Vienna 22
Nuremberg 21
Phoenix 21
Tashkent 21
Jinan 19
Norwalk 18
Amsterdam 17
Chennai 17
Da Nang 17
Changsha 16
Kunming 16
Johannesburg 15
Mexico City 15
Haiphong 14
Verona 14
Augusta 13
Brussels 13
Porto Alegre 13
Stockholm 13
Auburn Hills 12
Dublin 12
Orange 12
San Mateo 12
Sèlegas 12
Casablanca 11
Haverhill 11
Taizhou 11
Zhengzhou 11
Cairo 10
Miami 10
New Delhi 10
Poplar 10
Quito 10
Rio de Janeiro 10
Santiago 10
Totale 206.185
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.776
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.146
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.184
Maternal immune activation disrupts dopamine system in the offspring 4.163
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.490
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.388
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.362
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.329
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.048
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.963
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.829
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.749
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.733
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.611
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.565
null 2.498
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.467
Effects of maternal immune activation on dopamine activity in male and female offspring 2.463
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.392
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.361
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.320
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.236
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.187
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.172
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.131
Trattamenti farmacologici per la dipendenza da nicotina 2.059
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.026
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.017
The role of nuclear hormone receptors in cannabinoid function 1.959
Pharmacological treatments for nicotine dependence 1.919
Opposite responses to aversive stimuli in lateral habenula neurons 1.914
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.866
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.859
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.827
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.823
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.822
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.811
Neurobiologia della dipendenza da nicotina 1.806
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.805
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.788
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.781
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.760
Neurobiology of nicotine addiction 1.688
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.667
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.635
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.612
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.608
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.579
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.578
The endocannabinoid system and nondrug rewarding behaviours 1.462
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.453
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.429
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.417
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.416
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.374
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.369
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.353
Neurobiological mechanisms of cannabinoid addiction 1.300
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.275
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.172
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.136
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.127
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.108
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.105
Endocannabinoids and the processing of value-related signals 1.091
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.064
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.041
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.040
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.035
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 949
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 922
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 919
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 876
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 861
null 850
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 844
null 841
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 841
From surface to nuclear receptors: the endocannabinoid family extends its assets 821
null 800
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 764
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 764
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 757
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 754
null 747
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 742
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 727
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 722
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 721
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 716
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 667
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 654
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 626
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 610
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 599
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 594
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 576
A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions 516
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 515
Totale 200.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 271.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 271.535
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.051 0 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202313.833 966 1.337 1.295 1.077 1.299 1.630 730 1.290 1.109 1.039 1.411 650
2023/202449.729 650 566 535 849 1.467 2.427 2.628 1.101 927 889 1.632 36.058
2024/202520.925 3.816 4.750 2.828 2.973 1.635 1.653 1.772 185 396 248 377 292
2025/20269.310 861 442 989 783 660 652 1.659 555 627 1.215 580 287
2026/20271.613 785 828 0 0 0 0 0 0 0 0 0 0
Totale 213.111